Identification of predictive biomarkers for dasatinib treatment of metastatic melanoma.

dc.contributor.author	O'Driscoll, Lorraine	en
dc.date.accessioned	2016-08-02T11:16:49Z
dc.date.available	2016-08-02T11:16:49Z
dc.date.created	2011	en
dc.date.issued	2011	en
dc.date.submitted	2011	en
dc.identifier.citation	Eustace AJ, Kennedy S, Larkin A, Mahgoub T, Tryfonopoulos D, O'Driscoll L, Clynes M, Crown J, O'Donovan N., Identification of predictive biomarkers for dasatinib treatment of metastatic melanoma., J. Clin. Oncol., Amer. Soc. Clin. Oncol., Chicago, US, 2011, 29, 15, 2011, 8578 - 8578	en
dc.identifier.other	Y	en
dc.description	PUBLISHED	en
dc.description	Chicago, US	en
dc.format.extent	8578	en
dc.format.extent	8578	en
dc.relation.ispartofseries	29	en
dc.relation.ispartofseries	15	en
dc.rights	Y	en
dc.title	Identification of predictive biomarkers for dasatinib treatment of metastatic melanoma.	en
dc.title.alternative	J. Clin. Oncol.	en
dc.title.alternative	Amer. Soc. Clin. Oncol.	en
dc.type	Published Abstract	en
dc.type.supercollection	scholarly_publications	en
dc.type.supercollection	refereed_publications	en
dc.identifier.peoplefinderurl	http://people.tcd.ie/lodrisc	en
dc.identifier.rssinternalid	101221	en
dc.rights.ecaccessrights	openAccess
dc.subject.TCDTheme	Cancer	en
dc.subject.TCDTheme	Genes & Society	en
dc.identifier.rssuri	http://meeting.ascopubs.org/cgi/content/abstract/29/15_suppl/8578	en
dc.identifier.orcid_id	0000-0002-9860-8262	en
dc.identifier.uri	http://hdl.handle.net/2262/76772

Browse